This plan amendment updates the District of Columbia Medicaid Program to exclude certain high-cost curative therapy drug products from the DRG reimbursement system and shall be reimbursed under fee-for-service (FFS).
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media